Abstract:Background Osteoporosis in patients with systemic lupus erythematosus (SLE) is always thought to be GIOP (induced by glucocorticoid). Yet in our practice, there were some patients who developed osteoporosis at the onset of SLE, before the use of glucocorticoid and immunosuppressants. The clinical feature of these patients were not known by us clearly. Objectives This study aimed to investigate the BMD (bone marrow density) status and clinical characteristics of treatment-naive patients with newly diagnosed SLE. Methods Patients admitted to Peking University Third Hospital from 2009-2016, who were newly diagnosed as SLE and had no previous medical history that would had affected their BMD, were enrolled in this study. Demographic and clinical data were recorded. BMD of the lumbar vertebrae and femoral necks were measured with dual-energy X-ray absorptiometry, and patients were stratified as normal and abnormal BMD groups (including ostepenia and osteoporosis). Results Eighty-nine SLE patients with a mean age of 28.7 ± 8.9 years were included in the study (Table1). Approximately 36% of these patients had normal BMD, 49% had osteopenia, and 15% had osteoporosis. The SLE Disease Activity Index (SLEDAI) in the abnormal BMD group was lower than that in the normal BMD group (9.4 ± 4.5 vs 12.1 ± 5.8, P= 0.028). The body mass index (BMI) was significantly lower in the abnormal than normal BMD group (20.5±3.5 kg/m2 vs 24.2±3.2 kg/m2, P = 0.00). The total cholestenone (TC) and low density lipoprotein (LDL) were lower in the abnormal than normal BMD group (4.3±1.7 mmol/L vs 2.4±1.2 mmol/L, P =0.04; 4.9±1.3 mmol/L vs 2.9±0.9 mmol/L, P = 0.033). The multisystem damage and nervous system involvement were less in the abnormal than normal BMD group (χ2 = 5.996, P = 0.014 and χ2= 8.169, P = 0.004). Multivariate analysis showed that BMI (correlation coefficient = 0.484, P Conclusion Low BMI, SLEDAI and less multisystem damage may be risk factors of BMD abnormalities in newly diagnosed SLE patients. References [1] Rivas-Larrauri, F. and M.A. Yamazaki-Nakashimada, Systemic Lupus Erythematosus: Is It One Disease? Reumatologia Clinica (English Edition), 2016. 12(5): p. 274-281. [2] Bultink, I.E. and W.F. Lems, Systemic lupus erythematosus and fractures. RMD Open, 2015. 1(Suppl 1): p. e000069. [3] ROSALIND RAMSEY-GOLDMAN, J.E.D., CHENG-FANG HUANG,et al, FREQUENCY OF FRACTURES IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS Comparison with United States Population Data. ARTHRITIS & RHEUMATISM, 1999. 42. [4] Carli, L., et al., Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. Lupus Sci Med, 2016. 3(1): p. e000098. Acknowledgement This study was supported by a Project of the National Natural Science Foundation of China (81501390). Disclosure of Interests None declared

Relationship between the expression of estrogen receptor and bone mineral density in patients with initial systemic lupus erythematosus

The relationship of vitamin D endocrine system and estrogen receptor expression with bone mineral density in initial systemic lupus erythematosus

Peripheral CD24hi CD27+ CD19+ B Cells Subset As a Potential Biomarker in Naïve Systemic Lupus Erythematosus.

Prevalence and Possible Risk Factors of Low Bone Mineral Density in Untreated Female Patients with Systemic Lupus Erythematosus

The Significance of the RANKL and OPG Gene Expression in the Initial Systemic Lupus Erythematosus Patients

AB0501 CLINICAL ANALYSIS OF BONE MINERAL DENSITY IN PATIENTS WITH NEW-ONSET SYSTEMIC LUPUS ERYTHEMATOUS

Clinical analysis of bone mineral density in patients with newly diagnosed untreated systemic lupus erythematous

Abnormal Expression of Cd43 in Patients with Systemic Lupus Erythematosus and Its Clinical Significance

Assessment of Bone Mineral Density and Bone Metabolism in Young Male Adults Recently Diagnosed with Systemic Lupus Erythematosus in China.

Study of Bone Mineral Density and Serum Bone Turnover Markers in Newly Diagnosed Systemic Lupus Erythematosus Patients

The significance of the vitamin D anti vitamin D receptor In the initial systemic lupus erythematosus patients

Determinants of bone mineral density in systemic lupus erythematosus

Serum vitamin D level in patients with systemic lupus erythematosus and its relationship with bone mineral density

Assessment of the Risk of Low Bone Mineral Density in Premenopausal Japanese Female Patients with Systemic Lupus Erythematosus

Uncoupled Bone Remodeling is Characteristic of Bone Damage in Premenopausal Women with New-Onset Systemic Lupus Erythematosus.

Prevalence and Risk Factors of Reduced Bone Mineral Density in Systemic Lupus Erythematosus Patients: A Meta-Analysis.

Estrogen receptor α and vitamin D receptor gene polymorphisms and bone mineral density: association study of healthy pre- and postmenopausal Chinese women

High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus

[The Effect of Long-Term Low Dose Prednisone on Bone Mineral Density in Patients with Systemic Lupus Erythematosus].

Systemic lupus erythematosus-associated osteoporosis and its influencing factors

Test of linkage and/or association between the estrogen receptor ? gene with bone mineral density in Caucasian nuclear families